CASI Pharmaceuticals: Funding, Investors & Team (Sep 2026)
CASI Pharmaceuticals, Inc. is a biopharmaceutical company in the United States that is dedicated to creating and selling new therapies and drugs in China, the U.S., and globally. The company is specifically interested in expanding its offerings in hematology oncology and other areas where there is a demand for medical treatments. CASI is working towards becoming a top player in the biopharmaceutical industry by introducing medicines in the Chinese market using its expertise in regulation and commercialization in China, as well as its knowledge in global drug development.
CASI Pharmaceuticals has raised $35.0M across 2 funding rounds on record, the most recent an undisclosed round of $20.0M announced in Dec 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
CASI Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Dec 2025.
CASI Pharmaceuticals Funding Rounds
CASI Pharmaceuticals raised $15.0M in an undisclosed round announced in Jun 2024.
1.5 years later, an undisclosed round of $20.0M was announced in Dec 2025.
CASI Pharmaceuticals Founders and Leadership Team
No contact details are on record for this team yet.
CASI Pharmaceuticals Funding Compared to Other Biotechnology Startups
CASI Pharmaceuticals' latest round of $20.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like CASI Pharmaceuticals in Biotechnology and Rockville
Companies Similar to CASI Pharmaceuticals
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
CASI Pharmaceuticals Funding FAQs
What does CASI Pharmaceuticals do?
CASI Pharmaceuticals, Inc. is a biopharmaceutical company in the United States that is dedicated to creating and selling new therapies and drugs in China, the U.S., and globally. The company is specifically interested in expanding its offerings in hematology oncology and other areas where there is a demand for medical treatments. CASI is working towards becoming a top player in the biopharmaceutical industry by introducing medicines in the Chinese market using its expertise in regulation and commercialization in China, as well as its knowledge in global drug development.
How much funding has CASI Pharmaceuticals raised?
CASI Pharmaceuticals has raised $35.0M across 2 rounds on record. The most recent is an undisclosed round of $20.0M announced in Dec 2025.
When did CASI Pharmaceuticals last raise funding?
CASI Pharmaceuticals' most recent funding round on record is an undisclosed round of $20.0M, announced in Dec 2025.
Who founded CASI Pharmaceuticals?
FundedIQ lists John W Holaday (Founder) at CASI Pharmaceuticals.
Where is CASI Pharmaceuticals headquartered?
CASI Pharmaceuticals is based in Rockville, Maryland, United States.
How many employees does CASI Pharmaceuticals have?
CASI Pharmaceuticals is in the 101-250 employee band.
How does CASI Pharmaceuticals' funding compare to other Biotechnology startups?
CASI Pharmaceuticals' latest round of $20.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's CASI Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CASI Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.